Back to Search Start Over

An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis

Authors :
Shivankari Krishnananthasivam
Hao Li
Rania Bouzeyen
Bhuvaneshwari Shunmuganathan
Kiren Purushotorman
Xinlei Liao
Fengjiao Du
Claudia Guldager Kring Friis
Felicity Crawshay-Williams
Low Heng Boon
Qian Xinlei
Conrad En Zuo Chan
Radoslaw Sobota
Mary Kozma
Valeria Barcelli
Guirong Wang
Hairong Huang
Andreas Floto
Pablo Bifani
Babak Javid
Paul A. MacAry
Source :
npj Vaccines, Vol 8, Iss 1, Pp 1-12 (2023)
Publication Year :
2023
Publisher :
Nature Portfolio, 2023.

Abstract

Abstract Tuberculosis (TB) is an airborne disease caused by Mycobacterium tuberculosis (Mtb). Whilst a functional role for humoral immunity in Mtb protection remains poorly defined, previous studies have suggested that antibodies can contribute towards host defense. Thus, identifying the critical components in the antibody repertoires from immune, chronically exposed, healthy individuals represents an approach for identifying new determinants for natural protection. In this study, we performed a thorough analysis of the IgG/IgA memory B cell repertoire from occupationally exposed, immune volunteers. We detail the identification and selection of a human monoclonal antibody that exhibits protective activity in vivo and show that it targets a virulence factor LpqH. Intriguingly, protection in both human ex vivo and murine challenge experiments was isotype dependent, with most robust protection being mediated via IgG2 and IgA. These data have important implications for our understanding of natural mucosal immunity for Mtb and highlight a new target for future vaccine development.

Details

Language :
English
ISSN :
20590105
Volume :
8
Issue :
1
Database :
Directory of Open Access Journals
Journal :
npj Vaccines
Publication Type :
Academic Journal
Accession number :
edsdoj.b24451097c804d2ba5f67b2d5c67eea3
Document Type :
article
Full Text :
https://doi.org/10.1038/s41541-023-00710-1